Comparison of the effect of latanoprost 0.005% and Timolol 0.5% on the Calculated ocular perfusion pressure in patients with normal-tension glaucoma

American Journal of Ophthalmology

Volumn 125, Issue 5, 1998, Pages 585-592

  Drance, Stephen M ^a   Crichton, Andrew ^b   Mills, Richard P ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TIMOLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; GLAUCOMA; HEART RATE; HUMAN; INTRAOCULAR PRESSURE; MALE; MULTICENTER STUDY; PERFUSION PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TOPICAL DRUG ADMINISTRATION;

EID: 0032077339     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00019-1     Document Type: Article

References (17)

1. Hayreh S.S., Zimmerman M.B., Podhajsky P., Alward W.L.M. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 117:1994;603-624.
2. Graham S.L., Drance S.M., Wijsman K., Douglas G.R., Mikelberg F.S. Ambulatory blood pressure monitoring in glaucoma the nocturnal dip . Ophthalmology. 102:1995;61-69.
3. McMahon C.D., Shaffer R.N., Hoskins H.D., Bachorik P.S., Quigley H.A. Adverse effects experienced by patients taking timolol. Am J Ophthalmol. 88:1979;736-738.
4. Diggory P., Cassels-Brown A., Vail A., Abbey L.M., Hillman J.S. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet. 345:1995;1604-1606.
5. Frishman W.H., Fuksbrumer M.S., Tannenbaum M. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension. J Clin Pharmacol. 34:1994;795-803.
6. 2a analog, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
7. 2a analogue. In: Samuelsson B, editor. Advances in prostaglandin, thromboxane and leukotriene research. Volume 23. New York: Raven Press, 1995:513-518.
8. Alm A., Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost once daily, evening or morning a comparison with timolol . Ophthalmology. 102:1995;1743-1752.
9. Watson P., Stjernschantz J. A six-month randomized double-masked study comparing latanoprost to timolol in open-angle glaucoma and ocular hypertension. Ophthalmology. 103:1996;126-137.
10. Camras C.B. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. Ophthalmology. 103:1996;138-147.
11. Camras C.B., Alm A., Watson P. Glaucoma treatment for 1 year with latanoprost, a prostaglandin analog, in the USA, Scandinavia and UK. Ophthalmology. 103:1996;1916-1924.
12. Rulo A.H., Greve E.L., Hoyng P.F.J. The ocular hypotensive effect of latanoprost in normal-pressure glaucoma patients. ARVO abstracts. Invest Ophthalmol Vis Sci. 36:(4suppl):1995;A3421.
13. Bill A. Physiological aspects of the circulation in the optic nerve. Heilmann K., Richardson K.T. Glaucoma: conceptions of a disease, pathogenesis, diagnosis, therapy. 1978;97-103 Stuttgart, Georg Thieme.
14. Tielsch J.M., Katz J., Sommer A., Quigley H.A., Javitt J.C. Hypertension, perfusion pressure and primary open-angle glaucoma. Arch Ophthalmol. 113:1995;216-221.
15. Fraunfelder E.T. Ocular beta-blocker and systemic side effects. Arch Intern Med. 146:1986;1073-1074.
16. Nicolela M.T., Buckley A.R., Walman B.E., Drance S.M. A comparative study of the effects of timolol and latanoprost on the blood flow velocity of the retrobulbar vessels. Am J Ophthalmol. 122:1996;784-789.
17. Pillunat L.E., Stodtmeister R., Wilmanns I., Christ T.H. The autoregulation of ocular blood flow during changes in intraocular pressure preliminary results . Graefes Arch Clin Exp Ophthalmol. 223:1985;219-223.